Incyte
INCY
#1149
Rank
$20.70 B
Marketcap
$103.66
Share price
5.54%
Change (1 day)
54.12%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $1.71 Billion USD

According to Incyte's latest financial reports the company's total liabilities are $1.71 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$1.79 B-10.33%
2024-12-31$1.99 B25.4%
2023-12-31$1.59 B8.25%
2022-12-31$1.47 B26.43%
2021-12-31$1.16 B22.5%
2020-12-31$0.94 B14.64%
2019-12-31$0.82 B15.08%
2018-12-31$0.71 B7.12%
2017-12-31$0.67 B-44.88%
2016-12-31$1.21 B45.78%
2015-12-31$0.83 B-4.76%
2014-12-31$0.87 B6.74%
2013-12-31$0.82 B62.78%
2012-12-31$0.50 B-9.11%
2011-12-31$0.55 B-3.84%
2010-12-31$0.57 B-29.03%
2009-12-31$0.81 B79.81%
2008-12-31$0.45 B4.12%
2007-12-31$0.43 B-0.75%
2006-12-31$0.43 B11.44%
2005-12-31$0.39 B-10.24%
2004-12-31$0.43 B94.66%
2003-12-31$0.22 B-9.82%
2002-12-31$0.24 B-5.89%
2001-12-31$0.26 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
$79.60 B 4,538.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$117.21 B 6,729.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 4,874.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.31 B 4,754.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.53 B-68.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.34 B-79.92%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$0.13 B-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$72.38 M-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.35 B-79.26%๐Ÿ‡บ๐Ÿ‡ธ USA